Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 32,659 shares at $3.59 ($117K) on 2016-04-11, disclosed to the SEC on 2016-04-13.
Open-market purchase of $117k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.45 | 5,300 | $18K | 15.7% |
| 2 | $3.59 | 5,259 | $19K | 16.2% |
| 3 | $3.59 | 22,100 | $79K | 68.1% |
| Total | $3.57 avg | 32,659 | $117K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |